Literature DB >> 1690669

Interactions of papaya proteinase IV with inhibitors.

D J Buttle1, A Ritonja, P M Dando, M Abrahamson, E N Shaw, P Wikstrom, V Turk, A J Barrett.   

Abstract

Papaya proteinase IV (PPIV) is not inhibited by chicken cystatin, or human cystatins A or C, unlike most other proteinases of the papain superfamily. The enzyme inactivates chicken cystatin and human cystatin C by limited proteolysis of the glycyl bond previously shown to be involved in the inhibitory inactivity of the cystatins, but has no action on cystatin A. Contamination of commercial crystalline papain with PPIV accounts for the limited proteolysis of cystatins by 'papain' reported previously. PPIV is slowly bound by human alpha 2-macroglobulin. The enzyme is irreversibly inactivated by E-64, and by peptidyl diazomethanes containing glycine in P1 and a hydrophobic side-chain in P2. The reaction of PPIV with iodoacetate is extremely slow. PPIV is inhibited by peptide aldehydes despite the presence of bulky sidechains in P1, suggesting that these reversible inhibitors do not bind as substrate analogues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690669     DOI: 10.1016/0014-5793(90)80153-a

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Characterization by rapid-kinetic and equilibrium methods of the interaction between N-terminally truncated forms of chicken cystatin and the cysteine proteinases papain and actinidin.

Authors:  P Lindahl; M Nycander; K Ylinenjärvi; E Pol; I Björk
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

2.  Local pH-dependent conformational changes leading to proteolytic susceptibility of cystatin C.

Authors:  P J Berti; A C Storer
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

3.  Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.

Authors:  A Hall; H Dalbøge; A Grubb; M Abrahamson
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

4.  Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin.

Authors:  P Lindahl; M Abrahamson; I Björk
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

5.  Structure of chymopapain M the late-eluted chymopapain deduced by comparative modelling techniques and active-centre characteristics determined by pH-dependent kinetics of catalysis and reactions with time-dependent inhibitors: the Cys-25/His-159 ion-pair is insufficient for catalytic competence in both chymopapain M and papain.

Authors:  M P Thomas; C M Topham; D Kowlessur; G W Mellor; E W Thomas; D Whitford; K Brocklehurst
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

6.  Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase.

Authors:  M Abrahamson; R W Mason; H Hansson; D J Buttle; A Grubb; K Ohlsson
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

7.  The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms.

Authors:  Melanie Niemer; Ulrich Mehofer; Juan Antonio Torres Acosta; Maria Verdianz; Theresa Henkel; Andreas Loos; Richard Strasser; Daniel Maresch; Thomas Rademacher; Herta Steinkellner; Lukas Mach
Journal:  Biotechnol J       Date:  2014-04       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.